13.10.09:
Synectix to present their latest formulation research at AAPS in LA

Synectix Pharmaceutical Solutions Ltd are pleased to announce their forthcoming attendance at the 2009 AAPS Annual Meeting and Exposition International Conference in Los Angeles from 8th – 12th November 2009.

We will be presenting some of our latest internal research at the poster sessions, including:

• 1. Development of a modified release (MR) amorphous micro-tablet formulation of the poorly soluble active ingredient dipyridamole for targeted drug delivery.
• 2. A Novel Micro-Tablet Formulation for Targetted Delivery of Nanoparticulate Non Steroidal Anti Inflammatory Drugs (NSAIDs)
• 3. Characterisation of the bulk flow properties of a novel spray dried tobramycin powder for dry powder inhalation

Several Synectix representatives will be available to discuss this work, and indeed any aspect of preclinical poorly soluble drug development. To arrange a meeting with us, please contact us directly. We look forward to seeing you in LA!